FDA authorizes new antibody drug that targets Omicron COVID-19 variant
The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19. Go to Source February 12, 2022 – 6:06 am / Twitter: @hoffeldtcom